Long Term Extension Study for the Maintenance Treatment of Anemia Associated With Chronic Kidney Disease (CKD) in Hemodialysis Subjects on Epoetin Alfa / Beta Treatment Versus BAY85-3934



Status:Completed
Conditions:Renal Impairment / Chronic Kidney Disease, Renal Impairment / Chronic Kidney Disease, Renal Impairment / Chronic Kidney Disease, Anemia
Therapuetic Areas:Hematology, Nephrology / Urology
Healthy:No
Age Range:18 - Any
Updated:1/12/2017
Start Date:March 2014
End Date:November 2016

Use our guide to learn which trials are right for you!

A Controlled, Parallel Group, Open-label, Multicenter Extension Study to Investigate Efficacy and Safety of Oral BAY85-3934 and Active Comparator (Epoetin Alfa / Beta) in the Long-term Treatment of Subjects With Anemia Associated With Chronic Kidney Disease Who Are on Dialysis in the United States and Japan

Evaluate efficacy and safety up to 36 months of titrated dose treatment with BAY85-3934
versus epoetin alfa/beta. Titration will be based on the subject's hemoglobin (Hb) response
and tolerability of the prior dose. Planned doses include 15, 25, 50, 75, 100,and 150 mg
once daily.


Inclusion Criteria:

- Eligible male or female subjects were previously enrolled in Study 16208, have a
diagnosis of anemia associated with CKD, and are on hemodialysis.

- Men who agree to use adequate contraception when sexually active or women without
childbearing potential

- Participation and completion of treatment in Study 16208; subjects must have received
16 weeks of study medication and completed the end of treatment visit (Day 113) in
the parent study

- Mean Hb concentration of 9.5 to 11.5 g/dL, inclusive, during the evaluation period
(i.e., the last 4 weeks of the parent study) when the subject completed 16 weeks of
treatment with BAY85-3934, epoetin alfa, or epoetin beta in Study 16208

Exclusion Criteria:

- A scheduled kidney transplant or any other organ transplant within the next 6 months
(being on a waiting list does not exclude the subject)

- Updates to medical and surgical history which meet the exclusion criteria in the
parent study

- Subjects treated with immunosuppressive therapy and the breast cancer resistant
protein (BCRP) substrates, irinotecan, topotecan, methotrexate, imatinib, and
lapatinib

- Sustained, poorly controlled arterial hypertension or hypotension at baseline,
defined as mean BP ≥ 180/110 mmHg or systolic BP < 95 mmHg, respectively

- Severe rhythm or conduction disorder (e.g., HR < 50 or > 110 bpm, atrial fibrillation
or flutter, prolonged QT > 500 msec, second or third degree atrioventricular [AV]
block)

- New York Heart Association Class III or IV congestive heart failure

- Severe hepatic insufficiency (defined as alanine aminotransferase [ALT], aspartate
aminotransferase [AST], or gamma-glutamyl transferase > 3 x the upper limit of norma
[ULN], total bilirubin > 2 mg/dL, or Child-Pugh B or C) or active hepatitis in the
investigator's opinion

- An ongoing SAE from Study 16208 that is assessed as related to study drug

- Alcohol or drug abuse
We found this trial at
34
sites
?
mi
from
Los Angeles, CA
Click here to add this to my saved trials
?
mi
from
Azusa, CA
Click here to add this to my saved trials
?
mi
from
Brooklyn, NY
Click here to add this to my saved trials
?
mi
from
Buffalo, NY
Click here to add this to my saved trials
?
mi
from
Cincinnati, OH
Click here to add this to my saved trials
?
mi
from
Creve Coeur, MO
Click here to add this to my saved trials
?
mi
from
Detroit, MI
Click here to add this to my saved trials
?
mi
from
Detroit, MI
Click here to add this to my saved trials
?
mi
from
Eatontown, NJ
Click here to add this to my saved trials
?
mi
from
Fort Worth, TX
Click here to add this to my saved trials
?
mi
from
Fort Worth, TX
Click here to add this to my saved trials
?
mi
from
Fort Worth, TX
Click here to add this to my saved trials
?
mi
from
Fresh Meadows, NY
Click here to add this to my saved trials
?
mi
from
Grand Prairie, TX
Click here to add this to my saved trials
?
mi
from
Houston, TX
Click here to add this to my saved trials
?
mi
from
Houston, TX
Click here to add this to my saved trials
?
mi
from
Long Beach, CA
Click here to add this to my saved trials
?
mi
from
Lynwood, CA
Click here to add this to my saved trials
?
mi
from
Mansfield, TX
Click here to add this to my saved trials
?
mi
from
Muroran,
Click here to add this to my saved trials
?
mi
from
Nashville, TN
Click here to add this to my saved trials
?
mi
from
New Port Richey, FL
Click here to add this to my saved trials
?
mi
from
Northridge, CA
Click here to add this to my saved trials
?
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
?
mi
from
Pembroke Pines, FL
Click here to add this to my saved trials
?
mi
from
Philadelphia, PA
Click here to add this to my saved trials
?
mi
from
San Antonio, TX
Click here to add this to my saved trials
?
mi
from
San Antonio, TX
Click here to add this to my saved trials
?
mi
from
San Antonio, TX
Click here to add this to my saved trials
?
mi
from
San Dimas, CA
Click here to add this to my saved trials
?
mi
from
Tempe, AZ
Click here to add this to my saved trials
?
mi
from
Toledo, OH
Click here to add this to my saved trials
?
mi
from
Whittier, CA
Click here to add this to my saved trials
?
mi
from
Whittier, CA
Click here to add this to my saved trials